Abstract:Objective To investigate the pathogenic microorganisms and drug resistance of chronic respiratory disease combined with low respiratory tract infection in order to help experiential anti-infection treatment to avoid the abuse of antibiotics and prevent drug resistance of the bacteria. Methods Clinical data,sputum culture and results of drug sensitive test of 104 patients with low respiratory tract bacterial infection admitted to the respiratory ward of the first hospital affiliated to Lanzhou University from September 2007 to August 2008 were retrospectively analyzed.All the patients had chronic respiratory basic diseases. Results A total of 236 bacterial culture were performed and 130 strains of pathogenic microorganisms were isolated in 104 patients,including 83 strains of gram-negative bacteria(63.8%),among which 25 strains were pseudomonas aeruginosa,14 strains were haemophilus influenza,12 strains were haemophilus parainfluenzae,8 strains were klebsiella pneumonia,7 strains were acinetobacter lwoffi,5 strains were acinetobacter baumannii and 12 strains were other bacteria;9 strains were gram-positive bacteria(7.0%),among which 4 strains were staphylococcus aureus,3 strains were streptococcus pneumonia and 2 strains were other bacteria;38 strains were fungi,among which 28 strains were candida albicans and 10 strains were aspergillus fumigates and other fungi.Pseudomonas aeruginosa was 88.0% sensitive to cefoperazone/sulbactam;haemophilus influenza was 100.0% sensitive to imipenem;haemophilus parainfluenzae was 91.7% sensitive to ceftriaxone and imipenem;acinetobacter lwoffi was 100.0% sensitive to cefoperazone/sulbactam and piperacillin/tazobactam;klebsiella pneumonia was 83.3% sensitive to cefoperazone/sulbactam;acinetobacter baumannii was 100.0% sensitive to cefoperazone/sulbactam and imipenem.Streptococcus pneumonia was 100.0% sensitive to cefotaxime and vancomycin and was 100.0% drug resistant to compound sulfamethoxazole;staphylococcus aureus was 100.0% sensitive to cefotaxime and vancomycin and was 100.0% drug resistant to clindamycin.Candida albicans and candida glabrata were 100.0% sensitive to fluconazole,ketoconazole,clotrimazole and miconazole;candida guilliermondii was 100.0% sensitive to fluconazole,amphotericin B,ketoconazole,clotrimazole,miconazole and nystatin and was 100.0% drug resistant to flucytosine. Conclusion The pathogenic microorganisms are mainly gram-negative bacteria in patients with chronic respiratory disease combined with low respiratory tract infection.Correct judgment of pathogenic bacteria in accordance with basic diseases,severity of disease and medication history is conducive to reasonable and effective anti-infection treatment.

Analysis of the transition of Acinetobacter sp' prevalence in low respiratory tract infection and their drug sensitivity

Drug resistance of Acinetobacter baumannii during 2009-2011

Clinical Distribution and Drug Resistance of 4 Non-Fermenting Bacteria of Lower Respiratory Tract Infection

Analysis on Distribution and Antibiotic Susceptibility of 127 Strains Acinetobacter

Drug resistance of Acinetobacter baumanniiin ICU and general wards: a comparative study

Surveillance of drug resistance of Acinetobacter spp. In lower respiratory tract samples

Analysis of Drug Resistance of Acinetobacter Baumanii in Patients with Ventilator-Associated Pneumonia in Intensive Care Unit

Analysis on clinical distribution and resistance characteristic of Acinetobacter baumannii isolated clinically from 2008-2012

Analysis of Changes in Drug Resistance of 250 Strains Acinetobacter Baumannii in Clinical Isolates from the Second Xiangya Hospital

Analysis on Distribution and Resistance Profile of Infections of Acinetobacter Baumannii in Xiangya Hospital in 2006

Study on risk factors and drug resistance of Acinetobacter in nosocomial infection in lower respiratory tract

Clinical distribution and antimicrobial resistance analysis of Acinetobacter baumannii isolates in a hospital during 2007-2010

Analysis of Resistant Profile and Risk Factor of Acquired Infections of Acinetobacter Baumanii

Change of antimicrobial resistance of Acinetobacter baumannii from sputum specimens obtained from hospitalized patients during 2007-2011

Analysis of clinical distribution and drug resistance in 139 strains of acinetobacter baumanii

Pathogen Distribution and Resistance Analysis in Lower Respiratory Tract Infections from Southwest Hospital of the Third Military Medical University in 2008

Analysis of distribution and drug resistance of Acinetobacter Baumannii infection in ICU

Research of Klebsiella Pneumoniae and Acinetobacter Baumannii Resistance Distribution Differences

Investigation of bacteria distribution and drug resistance of lower respairory tract infection of respairtory wards

Antibiotic Susceptibility of Clinical Isolates from Lower Respiratory Tract Infection Patients in Respiratory Ward

Investigation of Pathogenic Microorganisms and Drug Resistance of Chronic Respiratory Disease Combined with Low Respiratory Tract Infection